News

[Newsletter-6] NEWS/INFO

June 15, 2020. >> Breaking news / Edition spéciale << Download our...

More

[Newsletter-5] NEWS/INFOS

May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

More

In the News/ A la une

Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...

More

[Newsletter -4] NEWS/INFOS

May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

More

[Newsletter -3] NEWS/INFOS

May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

More

[Newsletter -2] NEWS /INFOS

May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

More

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

More

[Infographie] Traitement XAV19

Available here/Disponible ici

More

[Newsletter -1] NEWS / INFOS

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

More

In the news / A la une

Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...

More

Covid-19 : Xenothera cherche les moyens de finaliser un traitement

[Article presse ] Par Frédéric Thual- La Tribune , à Nantes  |  26/03/2020, 15:08 Avec...

More

COVID19 / XAV19 : Scientific and medical rationale

Français ci-dessous «  We are convinced that our treatment will be efficient, for...

More

Interview d'Odile Duvaux, présidente de XENOTHERA dans Les Echos

[Article Presse]   Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...

More

Le XAV19 de XENOTHERA, un traitement prometteur pour les cas graves de Coronavirus

[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...

More

XENOTHERA presents at Toulouse ONCOWEEK 2020

At ONCOWEEK 2020 that will take place in Toulouse on Feb. 3-5,...

More

The first patient has been injected 2 weeks ago

[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...

More

XENOTHERA receives approval for first in man Kidney Transplant Clinical Trial

Nantes, September 11th, 2019 – XENOTHERA announces it has received  Czech Republic regulatory...

More

XENOTHERA presents at ESOT 2019

    XENOTHERA will participate at ESOT 2019 that will take place...

More

Xenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

More

XENOTHERA to raise Series A

XENOTHERA has started to gather investors for a Series A round of...

More

XENOTHERA sponsors the realization of a fresco for the hospital by transplanted patients

Nantes, november 2017 The fresco, more than 8 meters long, has been...

More

XENOTHERA nominated for the Ernst&Young Entrepreneur Award

Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...

More